Monthly Archives: September 2025

Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis. More recently, it was approved for ulcerative colitis (UC) and Crohn’s disease. This brings a new option for people living with inflammatory bowel disease (IBD). … Continue reading →

This week, many will return to school, and it’s no secret that the back-to-school season often sparks a rise in infections and seasonal illnesses. While it may start in classrooms, it quickly spreads beyond schools, as parents and caregivers carry … Continue reading →